Literature DB >> 21467302

Complex regulation of GH autofeedback under dual-peptide drive: studies under a pharmacological GH and sex steroid clamp.

Johannes D Veldhuis1, Dana Erickson, John M Miles, Cyril Y Bowers.   

Abstract

To test the postulate that sex difference, sex steroids, and peptidyl secretagogues control GH autofeedback, 11 healthy postmenopausal women and 14 older men were each given 1) a single iv pulse of GH to enforce negative feedback and 2) continuous iv infusion of saline vs. combined GHRH/GHRP-2 to drive feedback escape during pharmacological estradiol (E(2); women) or testosterone (T; men) supplementation vs. placebo in a double-blind, prospectively randomized crossover design. By three-way ANCOVA, sex difference, sex hormone treatment, peptide stimulation, and placebo/saline responses (covariate) controlled total (integrated) GH recovery during feedback (each P < 0.001). Both sex steroid milieu (P = 0.019) and dual-peptide stimulation (P < 0.001) determined nadir (maximally feedback-suppressed) GH concentrations. E(2)/T exposure elevated nadir GH concentrations during saline infusion (P = 0.003), whereas dual-peptide infusion did so independently of T/E(2) and sex difference (P = 0.001). All three of sex difference (P = 0.001), sex steroid treatment (P = 0.005), and double-peptide stimulation (P < 0.001) augmented recovery of peak (maximally feedback-escaped) GH concentrations. Peak GH responses to dual-peptidyl agonists were greater in women than in men (P = 0.016). E(2)/T augmented peak GH recovery during saline infusion (P < 0.001). Approximate entropy analysis corroborated independent effects of sex steroid treatment (P = 0.012) and peptide infusion (P < 0.001) on GH regularity. In summary, sex difference, sex steroid supplementation, and combined peptide drive influence nadir, peak, and entropic measurements of GH release under controlled negative feedback. To the degree that the pharmacological sex steroid, GH, and dual-peptide clamps provide prephysiological regulatory insights, these outcomes suggest major determinants of pulsatile GH secretion in the feedback domain.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21467302      PMCID: PMC3118586          DOI: 10.1152/ajpendo.00054.2011

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  47 in total

1.  Hormone pulsatility discrimination via coarse and short time sampling.

Authors:  S M Pincus; M L Hartman; F Roelfsema; M O Thorner; J D Veldhuis
Journal:  Am J Physiol       Date:  1999-11

2.  Irregularity and asynchrony in biologic network signals.

Authors:  S M Pincus
Journal:  Methods Enzymol       Date:  2000       Impact factor: 1.600

3.  Short-term estradiol supplementation augments growth hormone (GH) secretory responsiveness to dose-varying GH-releasing peptide infusions in healthy postmenopausal women.

Authors:  S M Anderson; N Shah; W S Evans; J T Patrie; C Y Bowers; J D Veldhuis
Journal:  J Clin Endocrinol Metab       Date:  2001-02       Impact factor: 5.958

4.  Continuous 24-hour intravenous infusion of recombinant human growth hormone (GH)-releasing hormone-(1-44)-amide augments pulsatile, entropic, and daily rhythmic GH secretion in postmenopausal women equally in the estrogen-withdrawn and estrogen-supplemented states.

Authors:  W S Evans; S M Anderson; L T Hull; P P Azimi; C Y Bowers; J D Veldhuis
Journal:  J Clin Endocrinol Metab       Date:  2001-02       Impact factor: 5.958

5.  Somatostatin is required for masculinization of growth hormone-regulated hepatic gene expression but not of somatic growth.

Authors:  M J Low; V Otero-Corchon; A F Parlow; J L Ramirez; U Kumar; Y C Patel; M Rubinstein
Journal:  J Clin Invest       Date:  2001-06       Impact factor: 14.808

6.  Gender and sexual maturation-dependent contrasts in the neuroregulation of growth hormone secretion in prepubertal and late adolescent males and females--a general clinical research center-based study.

Authors:  J D Veldhuis; J N Roemmich; A D Rogol
Journal:  J Clin Endocrinol Metab       Date:  2000-07       Impact factor: 5.958

7.  Growth hormone (GH) secretion in patients with an inactivating defect of the GH-releasing hormone (GHRH) receptor is pulsatile: evidence for a role for non-GHRH inputs into the generation of GH pulses.

Authors:  F Roelfsema; N R Biermasz; R G Veldman; J D Veldhuis; M Frölich; W H Stokvis-Brantsma; J M Wit
Journal:  J Clin Endocrinol Metab       Date:  2001-06       Impact factor: 5.958

8.  Age-related variations in the neuroendocrine control, more than impaired receptor sensitivity, cause the reduction in the GH-releasing activity of GHRPs in human aging.

Authors:  E Arvat; G P Ceda; L Di Vito; J Ramunni; L Gianotti; F Broglio; R Deghenghi; E Ghigo
Journal:  Pituitary       Date:  1998-04       Impact factor: 4.107

9.  Secretory process regularity monitors neuroendocrine feedback and feedforward signaling strength in humans.

Authors:  J D Veldhuis; M Straume; A Iranmanesh; T Mulligan; C Jaffe; A Barkan; M L Johnson; S Pincus
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2001-03       Impact factor: 3.619

10.  Pre- versus postmenopausal age, estradiol, and peptide-secretagogue type determine pulsatile growth hormone secretion in healthy women: studies using submaximal agonist drive and an estrogen clamp.

Authors:  Susan B Hudson; Darrell R Schroeder; Joy N Bailey; Kristi L Mielke; Dana Erickson; John M Miles; Cyril Y Bowers; Johannes D Veldhuis
Journal:  J Clin Endocrinol Metab       Date:  2009-10-26       Impact factor: 5.958

View more
  3 in total

1.  Gender determines ACTH recovery from hypercortisolemia in healthy older humans.

Authors:  Animesh Sharma; Paul Aoun; Jean Wigham; Sue Weist; Johannes D Veldhuis
Journal:  Metabolism       Date:  2013-09-25       Impact factor: 8.694

2.  Regulated recovery of pulsatile growth hormone secretion from negative feedback: a preclinical investigation.

Authors:  Johannes D Veldhuis; Cyril Y Bowers
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-07-27       Impact factor: 3.619

3.  Network identification of hormonal regulation.

Authors:  Daniel J Vis; Johan A Westerhuis; Huub C J Hoefsloot; Ferdinand Roelfsema; Jan van der Greef; Margriet M W B Hendriks; Age K Smilde
Journal:  PLoS One       Date:  2014-05-22       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.